|
Q2 2025
|
124 |
5,509,809 |
NUVL, OSCR, VTRS, MRUS
|
13F-HR
|
8/14/2025 |
000121390025076586 |
|
Q1 2025
|
123 |
5,064,779 |
NUVL, VTRS, INTEGRA LIFESCIENCES HLDGS C, NBIX
|
13F-HR
|
5/15/2025 |
000121390025044138 |
|
Q4 2024
|
106 |
5,280,006 |
NUVL, VTRS, INTEGRA LIFESCIENCES HLDGS C, CNC
|
13F-HR
|
2/14/2025 |
000121390025014236 |
|
Q3 2024
|
443 |
6,692,805 |
NUVL, VTRS, CNC, MRUS
|
13F-HR
|
11/14/2024 |
000121390024098387 |
|
Q2 2024
|
433 |
6,010,510 |
NUVL, INSMED INC, VTRS, CNC
|
13F-HR
|
8/14/2024 |
000095015924000249 |
|
Q1 2024
|
367 |
5,748,069 |
NUVL, VTRS, CNC, LRMR
|
13F-HR
|
5/15/2024 |
000095015924000176 |
|
Q4 2023
|
222 |
5,415,638 |
NUVL, GLAUKOS CORP, VTRS, INVITAE CORP
|
13F-HR
|
2/14/2024 |
000095015924000096 |
|
Q3 2023
|
88 |
4,538,793 |
NUVL, GLAUKOS CORP, VTRS, INVITAE CORP
|
13F-HR
|
11/14/2023 |
000095015923000305 |
|
Q2 2023
|
101 |
4,684,196 |
NUVL, GLAUKOS CORP, VTRS, AMED
|
13F-HR
|
8/14/2023 |
000095015923000249 |
|
Q1 2023
|
106 |
4,485,670 |
NUVL, GLAUKOS CORP, NBIX, CPRX
|
13F-HR
|
5/15/2023 |
000095015923000173 |
|
Q4 2022
|
104 |
4,831,008 |
NUVL, GLAUKOS CORP, INVITAE CORP, NBIX
|
13F-HR
|
2/14/2023 |
000095015923000074 |
|
Q3 2022
|
131 |
5,023,740 |
NUVL, GLAUKOS CORP, AERIE PHARMACEUTICALS INC, INVITAE CORP
|
13F-HR
|
11/14/2022 |
000095015922000241 |
|
Q2 2022
|
127 |
4,848,381 |
GLAUKOS CORP, NUVL, VTRS, AHCO
|
13F-HR
|
8/15/2022 |
000095015922000199 |
|
Q1 2022
|
122 |
4,472,946 |
GLAUKOS CORP, NUVL, VTRS, AHCO
|
13F-HR
|
5/16/2022 |
000095015922000122 |
|
Q4 2021
|
127 |
4,767,581 |
NUVL, VTRS, AHCO, GLAUKOS CORP
|
13F-HR
|
2/14/2022 |
000095015922000077 |
|
Q3 2021
|
133 |
5,123,921 |
NUVL, VTRS, INVITAE CORP, AHCO
|
13F-HR
|
11/15/2021 |
000095015921000326 |
|
Q2 2021
|
143 |
5,629,668 |
VTRS, OMIC, INVITAE CORP, CMAX
|
13F-HR
|
8/16/2021 |
000095015921000256 |
|
Q1 2021
|
133 |
4,758,345 |
INVITAE CORP, VTRS, NEVRO CORP, AERIE PHARMACEUTICALS INC
|
13F-HR
|
5/17/2021 |
000095015921000154 |
|
Q4 2020
|
129 |
5,059,782 |
VTRS, INVITAE CORP, NEVRO CORP, NUVASIVE INC
|
13F-HR
|
2/16/2021 |
000095015921000090 |
|
Q3 2020
|
105 |
4,106,901 |
INVITAE CORP, MYL, IMMU, NEVRO CORP
|
RESTATEMENT
|
12/30/2020 |
000095015920000284 |
|
Q2 2020
|
93 |
3,433,887 |
HORIZON PHARMA INVT LTD, MYL, NEVRO CORP, SDGR
|
13F-HR
|
8/14/2020 |
000095015920000206 |
|
Q1 2020
|
90 |
3,151,113 |
AHCO, MYL, HZNP, HORIZON PHARMA INVT LTD
|
13F-HR
|
5/15/2020 |
000095015920000137 |
|
Q4 2019
|
76 |
3,134,215 |
HORIZON PHARMA INVT LTD, AHCO, HZNP, MYL
|
13F-HR
|
2/14/2020 |
000095015920000051 |
|
Q3 2019
|
95 |
2,452,802 |
HZNP, HORIZON PHARMA INVT LTD, MYL, NEVRO CORP
|
13F-HR
|
11/14/2019 |
000095015919000232 |
|
Q2 2019
|
97 |
2,783,958 |
HZNP, HORIZON PHARMA INVT LTD, MYL, ORTX
|
13F-HR
|
8/14/2019 |
000156761919016972 |
|
Q1 2019
|
93 |
2,607,815 |
HORIZON PHARMA PLC, FIXX, ORTX, HORIZON PHARMA INVT LTD
|
13F-HR
|
5/15/2019 |
000156761919011266 |
|
Q4 2018
|
99 |
2,498,187 |
HORIZON PHARMA PLC, ORTX, FIXX, HORIZON PHARMA INVT LTD
|
13F-HR
|
2/14/2019 |
000156761919004367 |
|
Q3 2018
|
103 |
2,791,662 |
HORIZON PHARMA PLC, FIXX, HORIZON PHARMA INVT LTD, NEVRO CORP
|
13F-HR
|
11/14/2018 |
000156761918006280 |
|
Q2 2018
|
114 |
2,847,622 |
MNK, HORIZON PHARMA PLC, FIXX, HORIZON PHARMA INVT LTD
|
13F-HR
|
8/14/2018 |
000156761918001075 |
|
Q1 2018
|
118 |
2,886,303 |
MNK, MYL, FIXX, HORIZON PHARMA PLC
|
13F-HR
|
5/15/2018 |
000114036118023958 |
|
Q4 2017
|
98 |
2,540,877 |
MNK, MYL, HORIZON PHARMA PLC, DXCM
|
13F-HR
|
2/14/2018 |
000114036118008191 |
|
Q3 2017
|
91 |
2,219,958 |
AVXS, MCK, MYL, HORIZON PHARMA PLC
|
13F-HR
|
11/13/2017 |
000114036117042010 |
|
Q2 2017
|
85 |
1,874,767 |
AVXS, HORIZON PHARMA PLC, NXSTAGE MEDICAL INC, GILD
|
13F-HR
|
8/14/2017 |
000114036117031950 |
|
Q1 2017
|
106 |
2,592,841 |
AVXS, HORIZON PHARMA PLC, NXSTAGE MEDICAL INC, ENDOLOGIX INC
|
13F-HR
|
5/15/2017 |
000114036117020638 |
|
Q4 2016
|
102 |
2,430,288 |
HORIZON PHARMA PLC, NXSTAGE MEDICAL INC, AVXS, PTLA
|
13F-HR
|
2/14/2017 |
000114036117007402 |
|
Q3 2016
|
90 |
2,150,130 |
GWPH, PTLA, HORIZON PHARMA PLC, NXSTAGE MEDICAL INC
|
13F-HR
|
11/14/2016 |
000114036116086449 |
|
Q2 2016
|
106 |
2,544,485 |
HORIZON PHARMA PLC, NXSTAGE MEDICAL INC, GWPH, PTLA
|
13F-HR
|
8/15/2016 |
000114036116076356 |
|
Q1 2016
|
105 |
2,348,708 |
HORIZON PHARMA PLC, MYL, NXSTAGE MEDICAL INC, HEALTHWAYS INC
|
13F-HR
|
5/16/2016 |
000114036116065661 |
|
Q4 2015
|
109 |
2,467,381 |
HORIZON PHARMA PLC, NXSTAGE MEDICAL INC, DYAX, ADPTQ
|
13F-HR
|
2/16/2016 |
000114036116053179 |
|
Q3 2015
|
134 |
2,585,133 |
HORIZON PHARMA PLC, ALLSCRIPTS HEALTHCARE SOLUTN, NXSTAGE MEDICAL INC, GSK
|
13F-HR
|
11/16/2015 |
000114036115041667 |
|
Q2 2015
|
120 |
3,001,745 |
HORIZON PHARMA PLC, ALLSCRIPTS HEALTHCARE SOLUTN, AVDL, NXSTAGE MEDICAL INC
|
13F-HR
|
8/14/2015 |
000114036115032279 |
|
Q1 2015
|
1 |
1,044 |
CORSICANTO LTD
|
NEW HOLDINGS
|
8/14/2015 |
000114036115032272 |
|
Q1 2015
|
123 |
3,086,356 |
ASPX, HORIZON PHARMA PLC, ALLSCRIPTS HEALTHCARE SOLUTN, ABBV
|
13F-HR
|
5/15/2015 |
000114036115020245 |
|
Q4 2014
|
111 |
2,783,542 |
AUXL, ASPX, HORIZON PHARMA PLC, AGN
|
13F-HR
|
2/17/2015 |
000114036115007446 |
|
Q3 2014
|
131 |
2,743,289 |
AUXL, DENDREON CORP, AGN, NXSTAGE MEDICAL INC
|
13F-HR
|
11/14/2014 |
000114036114042282 |
|
Q2 2014
|
127 |
2,486,776 |
DENDREON CORP, AUXL, ITMN, AVDL
|
13F-HR
|
8/14/2014 |
000114036114032861 |
|
Q1 2014
|
124 |
2,449,414 |
DENDREON CORP, HUM calls, INTERMUNE INC, AVDL
|
13F-HR
|
5/15/2014 |
000114036114021676 |
|
Q4 2013
|
106 |
1,930,346 |
DENDREON CORP, AUXL, QCOR, CBST calls
|
13F-HR
|
2/14/2014 |
000114036114007925 |